Resveratrol acts as a mixed agonist/antagonist for estrogen receptors α and β

Endocrinology

Volumn 141, Issue 10, 2000, Pages 3657-3667

  Bowers, J L ^a   Tyulmenkov, V V ^a   Jernigan, S C ^a   Klinge, C M ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; PALINDROMIC DNA; RESVERATROL;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL PROLIFERATION; CHO CELL; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GENE ACTIVITY; GRAPE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

EID: 0033735389     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.10.7721     Document Type: Article

References (56)

1. Cancer chemoprevention activity of resveratrol, a natural product derived from grapes
2. Cancer chemopreventive activity of resveratrol
3. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines
4. The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury
5. Method to assay the concentrations of phenolic constituents of biological interest in wines
6. Plasma and tissue resveratrol concentrations and pharmacological activity
7. Evaluation of kinetic parameters of natural phytoalexin in resveratrol orally administered in wine to rats
8. Determination of trans-resveratrol in plasma by HPLC
9. Estrogenic/antiestrogenic and scavenging properties of (E)- and (Z)-resveratrol
10. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor
11. Estrogen-induced retinoic acid receptor alpha 1 gene expression: Role of estrogen receptor-Sp1 complex
12. Nuclear receptor coregulators: Cellular and molecular biology
13. The estrogen receptor beta subtype: A novel mediator of estrogen action in neuroendocrine systems
14. Partial and weak oestrogenicity of the red wine constituent resveratrol: Consideration of its superagonist activity in MCF-7 cells and its suggested cardiovascular protective effects
15. Human estrogen receptor β-gene structure, chromosomal localization, and expression pattern
16. Expression of estrogen receptor β messenger RNA variant in breast cancer
17. Basic guide to the mechanisms of antiestrogen action
18. Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells
19. Is resveratrol an estrogen agonist in growing rats?
20. COUP-TF interacts with estrogen receptor, binds to estrogen response elements and half-sites, and modulates estrogen-induced gene expression
21. Differential DNA-binding abilities of estrogen receptor occupied with two classes of antiestrogens: Studies using human estrogen receptor overexpressed in mammalian cells
22. Cloning of a novel estrogen receptor expressed in rat prostate and ovary
23. Comparison of tamoxifen ligands on estrogen receptor interaction with estrogen response elements
24. The aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT) heterodimer interacts with naturally occurring estrogen response elements
25. Hydroxylapatite 'batch' assay for estrogen receptor: Increased sensitivity over present receptor assays
26. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (150) of an enzymatic reaction
27. Hsp70 is not required for high affinity binding of purified calf uterine estrogen receptor to estrogen response element DNA in vitro
28. Antiproliferative effect of synthetic resveratrol on human breast epithelial cells
29. Dissociation of 4-hydroxytamoxifen, but not estradiol or tamoxifen aziridine, from the estrogen receptor when the receptor binds estrogen response element DNA
30. What differentiates antiestrogen-liganded versus estradiol-liganded estrogen receptor action?
31. A comparison of transcriptional activation by ER alpha and ER beta
32. Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol
33. Estrogen receptor affinity and location of consensus and imperfect estrogen response elements influence transcription activation of simplified promoters
34. Activation of transcription by estrogen receptor α and β is cell type- and promoter-dependent
35. Widely spaced, directly repeated PuGGTCA elements act as promiscuous enhancers for different classes of nuclear receptors
36. Cooperative binding of estrogen receptor to DNA depends on spacing of binding sites, flanking sequence, and ligand
37. Stability of the ligand of estrogen response element-bound estrogen receptor depends on flanking sequences and cellular factors
38. The estrogen receptor β-isoform (ERβ) of the human estrogen receptor modulates ERα transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens
39. Phytoestrogens: Epidemiology and a possible role in cancer prevention
40. A review of the clinical effects of phytoestrogens
41. Wine, alcohol, platelets, and the French paradox for coronary heart disease
42. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β
43. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β
44. Estrogen receptor (ER) modulators each induce distinct conformational changes in ER α and ER β
45. Comparative analyses of mechanistic differences among antiestrogens
46. Molecular basis of agonism and antagonism in the oestrogen receptor
47. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
48. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist
49. Stable overexpression of estrogen receptor-alpha in ECV304 cells inhibits proliferation and levels of secreted endothelin-1 and vascular endothelial growth factor
50. Overexpression of estrogen receptor in HTB 96 human osteosarcoma cells results in estrogen-induced growth inhibition and receptor cross talk
51. Characterization of a nontumorigenic human breast epithelial cell line stably transfected with the human estrogen receptor (ER) cDNA
52. Different estrogen receptor structural domains are required for estrogen- and tamoxifen-dependent anti-proliferative activity in human mammary epithelial cells expressing an exogenous estrogen receptor
53. Estrogen causes cell death of estrogen receptor stably transfected cells via apoptosis
54. Transcription activation by the human estrogen receptor subtype β (ER β) studied with ER β and ER α receptor chimeras
55. Resveratrol, map kinases and neuronal cells: Might wine be a neuroprotectant?
56. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation